Literature DB >> 3108666

Growth inhibition of pathogenic yeast isolates by alpha-difluoromethylornithine: an inhibition of ornithine decarboxylase.

M A Pfaller, T Gerarden, J Riley.   

Abstract

A large body of evidence exists suggesting that polyamines can play essential roles in cellular growth and differentiation. We examined the ability of alpha-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, the major rate-limiting enzyme in polyamine biosynthesis, to inhibit the growth of Candida albicans, C. tropicalis, and C. parapsilosis. Substantial growth-inhibition was observed for all three species at DFMO concentrations ranging from 1 to 100 mM. C. tropicalis was significantly more susceptible to DFMO than C. albicans or C. parapsilosis. Depletion of cellular polyamine pools was seen in all 3 species following exposure to DFMO and polyamine depletion enhanced the susceptibility of the organisms to DFMO. The action of DFMO was specifically antagonized by exogenous polyamines. These data suggest that polyamines are important in the growth of Candida spp. and that inhibitors of polyamine biosynthesis may be useful as antifungal agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108666     DOI: 10.1007/bf00431009

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  17 in total

1.  The effects of some polyamine biosynthetic inhibitors on growth and morphology of phytopathogenic fungi.

Authors:  M V Rajam; A W Galston
Journal:  Plant Cell Physiol       Date:  1985       Impact factor: 4.927

Review 2.  Polyamines in microorganisms.

Authors:  C W Tabor; H Tabor
Journal:  Microbiol Rev       Date:  1985-03

Review 3.  Spermine, spermidine and putrescine in fungal development.

Authors:  L Stevens; M D Winther
Journal:  Adv Microb Physiol       Date:  1979       Impact factor: 3.517

4.  Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine.

Authors:  A Sjoerdsma; J A Golden; P J Schechter; J L Barlow; D V Santi
Journal:  Trans Assoc Am Physicians       Date:  1984

Review 5.  Chemotherapeutic implications of polyamine biosynthesis inhibition.

Authors:  A Sjoerdsma; P J Schechter
Journal:  Clin Pharmacol Ther       Date:  1984-03       Impact factor: 6.875

Review 6.  Strategies in the treatment of systemic fungal infections.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1980-01-17       Impact factor: 91.245

Review 7.  Experimental approaches to antifungal chemotherapy.

Authors:  J F Ryley; R G Wilson; M B Gravestock; J P Poyser
Journal:  Adv Pharmacol Chemother       Date:  1981

8.  Systemic candidiasis in cancer patients.

Authors:  A W Maksymiuk; S Thongprasert; R Hopfer; M Luna; V Fainstein; G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

Review 9.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

10.  Prevention of a plant disease by specific inhibition of fungal polyamine biosynthesis.

Authors:  M V Rajam; L H Weinstein; A W Galston
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  3 in total

1.  Trichomonas vaginalis: characterization of ornithine decarboxylase.

Authors:  N Yarlett; B Goldberg; M A Moharrami; C J Bacchi
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

2.  Polyamine depletion and growth inhibition of Cryptococcus neoformans by alpha-difluoromethylornithine and cyclohexylamine.

Authors:  M A Pfaller; J Riley; T Gerarden
Journal:  Mycopathologia       Date:  1990-10       Impact factor: 2.574

Review 3.  Eflornithine. A new drug in the treatment of sleeping sickness.

Authors:  I Van Bogaert; A Haemers
Journal:  Pharm Weekbl Sci       Date:  1989-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.